The company's financial position is increasingly vulnerable, as total equity has eroded to $700.3 million by 2026Q1 while maintaining a debt-to-equity ratio of 0.55.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 |
|---|
| Total Current Assets | 712.02M | 762.62M | 681.96M | 903.16M | 1.07B | 1.1B | 806.13M | 527.05M | 249.77M | 180.25M | 169.24M | 166.94M | 125.3M | 122.53M | 88.1M | 83.33M | 86.69M | 68.96M | 93.08M | 111.84M | 113.82M | 81.97M | 65.5M | 34.74M |
| Cash & Short-Term Investments | 445.23M | 476.19M | 396.8M | 604.11M | 707.31M | 858.5M | 589.67M | 359.22M | 149.88M | 101.58M | 127.86M | 134.96M | 89.92M | 98.14M | 65.64M | 63.78M | 68.54M | 58.36M | 84.1M | 96.13M | 78.72M | 53.52M | 64.15M | 32.9M |
| Cash Only | 388.32M | 418.34M | 306.39M | 510.91M | 400.7M | 699.33M | 517.05M | 310.97M | 109.06M | 67.02M | 83.94M | 44.5M | 48.71M | 45.64M | 39.06M | 17.78M | 21.09M | 32.93M | 55.06M | 37.99M | 78.72M | 53.52M | 4.12M | 1.39M |
| Short-Term Investments | 56.91M | 57.85M | 90.41M | 93.2M | 306.61M | 159.17M | 72.62M | 48.25M | 40.82M | 34.56M | 43.92M | 90.46M | 41.21M | 52.49M | 26.57M | 46.01M | 47.45M | 25.43M | 29.03M | 58.14M | 0 | 0 | 60.03M | 31.51M |
| Accounts Receivable | 167.23M | 213.42M | 218.38M | 221.9M | 275.77M | 176.75M | 167.48M | 139.34M | 60.94M | 69.98M | 29.83M | 22.19M | 26.15M | 18.21M | 15.53M | 10.59M | 12.44M | 4.86M | 3.9M | 9.17M | 7.77M | 14.13M | 16.34M | 0 |
| Days Sales Outstanding | 94.43 | 102.87 | 100.02 | 103.65 | 133.95 | 104.39 | 122.03 | 113.92 | 59.25 | 99.14 | 66.18 | 63.44 | 106.63 | 77.34 | 64.97 | 48.26 | 82.15 | 41.53 | 35.97 | 101.75 | 42.11 | 80.43 | 3.08K | - |
| Inventory | 33.02M | 29.3M | 31.12M | 30.89M | 29.82M | 25.79M | 16.62M | 12.07M | 5.66M | 9.02M | 4.3M | 3.13M | 3.11M | 2.36M | 2.44M | 3.56M | 2.82M | 2.42M | 2.14M | 2.39M | 4.78M | 10.5M | 0 | 0 |
| Days Inventory Outstanding | 18.52 | 15.4 | 16.65 | 18.59 | 18.85 | 20.18 | 16.17 | 14.05 | 7.84 | 18.8 | 14.83 | 12.75 | 18.89 | 15.73 | 15.87 | 28.75 | 33.28 | 36.48 | 35.53 | 35.15 | 39.31 | 89.17 | - | - |
| Other Current Assets | 66.55M | 24.75M | 13.42M | 27.87M | 43.82M | 20.68M | 21.04M | 6.13M | 25.27M | 17.03M | 2.68M | 3.39M | 2.51M | 2.11M | 1.16M | 721K | 0 | 1.43M | 951K | 0 | 27.89M | 0 | 3.15M | 0 |
| Total Non-Current Assets | 929.5M | 1.02B | 1.23B | 1.35B | 1.18B | 1.13B | 1.03B | 852.81M | 522.11M | 487.02M | 182.13M | 121.6M | 99.3M | 104.85M | 137.32M | 134.88M | 105.17M | 77.64M | 89.82M | 96.04M | 91.71M | 104.14M | 5.41M | 6.99M |
| Property, Plant & Equipment | 531.39M | 554.39M | 823.94M | 806.56M | 650.2M | 484.6M | 412.7M | 268.53M | 90.52M | 74.66M | 43.42M | 38.33M | 24.05M | 24.24M | 27.18M | 24.95M | 18.49M | 19.16M | 18.47M | 18.46M | 34.67M | 38.16M | 4.44M | 4.46M |
| Fixed Asset Turnover | 1.16x | 1.37x | 0.97x | 0.97x | 1.16x | 1.28x | 1.21x | 1.66x | 4.15x | 3.45x | 3.79x | 3.33x | 3.72x | 3.55x | 3.21x | 3.21x | 2.99x | 2.23x | 2.14x | 1.78x | 1.94x | 1.68x | 0.44x | 0.80x |
| Goodwill | 0 | 272.25M | 282.85M | 275.63M | 274.82M | 257.57M | 302.67M | 287.27M | 220.79M | 220.18M | 93.23M | 45.65M | 44.81M | 40.14M | 42.34M | 42.2M | 25.98M | 16.56M | 13.29M | 39.04M | 48.91M | 0 | 0 | 0 |
| Intangible Assets | 0 | 31.56M | 26.44M | 15.45M | 23.82M | 30.85M | 119.95M | 131.33M | 122.99M | 135.03M | 22.45M | 25.15M | 30.21M | 39.83M | 63.27M | 67.65M | 57.62M | 29.01M | 47.17M | 37.48M | 42.99M | 14.13M | 16.34M | 0 |
| Long-Term Investments | 218.02M | 52.61M | 42.15M | 142.09M | 150.33M | 287.01M | 72.22M | 46.31M | 28.99M | 22.14M | 3.97M | 80K | 91K | 87K | 85K | -45.93M | 3.09M | 10K | 427K | -57.06M | -20.47M | -93.44M | 0 | 0 |
| Other Non-Current Assets | 37.33M | 36.84M | 37.82M | 95.23M | 74.08M | 56.84M | 45.73M | 26.56M | 15.5M | 15.77M | 8.47M | 3.57M | 139K | 566K | 1.63M | 46.01M | 3.09M | 12.9M | 10.47M | 58.12M | 1.98M | 159.42M | 192.53K | 779.74K |
| Total Assets | 1.64B | 1.78B | 1.91B | 2.25B | 2.26B | 2.24B | 1.84B | 1.38B | 771.88M | 667.27M | 351.37M | 288.54M | 224.6M | 227.38M | 225.43M | 218.21M | 191.86M | 146.6M | 182.9M | 207.88M | 205.53M | 186.11M | 70.91M | 41.73M |
| Asset Turnover | 0.41x | 0.43x | 0.42x | 0.35x | 0.33x | 0.28x | 0.27x | 0.32x | 0.49x | 0.39x | 0.47x | 0.44x | 0.40x | 0.38x | 0.39x | 0.37x | 0.29x | 0.29x | 0.22x | 0.16x | 0.33x | 0.34x | 0.03x | 0.09x |
| Asset Growth % | -50.03% | -7.03% | -15.09% | -0.21% | 0.99% | 21.63% | 33.18% | 78.76% | 15.68% | 89.91% | 21.77% | 28.47% | -1.22% | 0.87% | 3.31% | 13.74% | 30.87% | -19.85% | -12.02% | 1.14% | 10.43% | 162.46% | 69.94% | - |
| Total Current Liabilities | 423.82M | 367.92M | 344.58M | 464.57M | 337.71M | 324.52M | 255.06M | 200.88M | 196.28M | 245.78M | 73.39M | 56.4M | 33.07M | 38.95M | 33.88M | 42.83M | 32.8M | 26.45M | 21.83M | 24.34M | 55.48M | 29.67M | 7.61M | 5.15M |
| Accounts Payable | 54.96M | 64.74M | 85.79M | 134.32M | 97.28M | 72.6M | 52.06M | 35.16M | 31.14M | 26.08M | 12M | 12.17M | 9.45M | 6.65M | 6.36M | 10.13M | 6.98M | 5.24M | 7.19M | 15.09M | 11.48M | 8.11M | 1.25M | 543.91K |
| Days Payables Outstanding | 32.77 | 34.02 | 45.91 | 80.85 | 61.49 | 56.8 | 50.65 | 40.92 | 43.15 | 54.37 | 41.33 | 49.53 | 57.37 | 44.38 | 41.29 | 81.94 | 82.41 | 78.76 | 119.43 | 221.58 | 94.37 | 68.87 | - | - |
| Short-Term Debt | 88.71M | 103.64M | 50.8M | 149.1M | 1.56M | 36.14M | 36.72M | 23.27M | 55.07M | 167.76M | 21.41M | 14.21M | 13.36M | 17.22M | 13.22M | 13.17M | 8.58M | 10.27M | 2.58M | 1.3M | 2.59M | 6.04M | 1.05M | 1.25M |
| Deferred Revenue (Current) | 383.38M | 108.02M | 109.81M | 107.86M | 136.67M | 126.78M | 86.44M | 82.4M | 61.19M | 18.99M | 15.91M | 8.86M | 3.35M | 6.28M | 5.78M | 18.19M | 7.67M | 5.48M | 1.24M | 6.58M | 12.68M | 7.5M | 3.37M | 0 |
| Other Current Liabilities | 155.82M | 41.18M | 84.21M | 45.83M | 76.54M | 63.93M | 31.68M | 17.17M | 16.74M | 29.44M | 10.23M | 6.91M | 6.91M | 6.67M | 5.36M | 13.13M | 7.26M | 4.99M | 8.74M | 7.06M | 40.21M | 11.67M | 5.28M | 3.03M |
| Current Ratio | 1.68x | 2.07x | 1.98x | 1.94x | 3.18x | 3.39x | 3.16x | 2.62x | 1.27x | 0.73x | 2.31x | 2.96x | 3.79x | 3.15x | 2.60x | 1.95x | 2.64x | 2.61x | 4.26x | 4.60x | 2.05x | 2.76x | 8.61x | 6.74x |
| Quick Ratio | 1.60x | 1.99x | 1.89x | 1.88x | 3.09x | 3.31x | 3.10x | 2.56x | 1.24x | 0.70x | 2.25x | 2.90x | 3.70x | 3.08x | 2.53x | 1.86x | 2.56x | 2.52x | 4.17x | 4.50x | 1.97x | 2.41x | 8.61x | 6.74x |
| Cash Conversion Cycle | 80.18 | 84.25 | 70.76 | 41.39 | 91.31 | 67.77 | 87.56 | 87.04 | 23.95 | 63.57 | 39.68 | 26.66 | 68.15 | 48.69 | 39.54 | -4.93 | 33.03 | -0.74 | -47.93 | -84.69 | -12.95 | 100.74 | - | - |
| Total Non-Current Liabilities | 517.36M | 596.72M | 615.39M | 667.99M | 732.36M | 532.96M | 696.2M | 643.51M | 150.73M | 89.75M | 64.04M | 45.04M | 33.15M | 29.46M | 39M | 28.14M | 26.42M | 8.67M | 11.21M | 12.99M | 12.88M | 7.77M | 1.58M | 543.12K |
| Long-Term Debt | 299.16M | 194.82M | 392.74M | 477.11M | 328.3M | 326.34M | 405.02M | 364.68M | 54.68M | 20.3M | 7.19M | 8.73M | 8.19M | 0 | 4.18M | 2.36M | 3.5M | 3.76M | 8.05M | 9.13M | 6.3M | 3.4M | 1.58M | 543.12K |
| Capital Lease Obligations | 149.04M | 149.04M | 0 | 170.03M | 162M | 135.96M | 160.21M | 131.87M | 2.87M | 1.17M | 30K | 0 | 0 | 14K | 0 | 1K | 32K | 132K | 346K | 700K | 1.83M | 2.13M | 0 | 0 |
| Deferred Tax Liabilities | 121.92M | 79.51M | 14.52M | 18.14M | 18.52M | 17.69M | 73.39M | 78.08M | 21.52M | 23.5M | 115K | 1.54M | 1.58M | 1.25M | 2.1M | 9.9M | 6.66M | 1.98M | 1.46M | 1.6M | 6.45M | 0 | 0 | 0 |
| Other Non-Current Liabilities | 65.58M | 19.74M | 20.9M | -152.57M | 17.4M | 18.49M | 25.62M | 25.3M | 20.62M | 16.11M | 15.57M | 28.27M | 19.04M | 19.82M | 20.2M | 15.86M | 12.72M | 832K | 779K | 1.02M | -2.82M | 1.51M | 0 | 0 |
| Total Liabilities | 941.17M | 964.64M | 959.98M | 1.13B | 1.07B | 857.48M | 951.26M | 844.39M | 347M | 335.52M | 137.43M | 101.44M | 66.22M | 68.41M | 72.88M | 70.97M | 59.22M | 35.11M | 33.04M | 37.33M | 68.35M | 37.44M | 9.18M | 5.7M |
| Total Debt | 387.87M | 447.5M | 443.54M | 815.35M | 506.67M | 512.92M | 601.94M | 519.83M | 114.47M | 189.93M | 28.83M | 22.94M | 21.55M | 17.24M | 17.4M | 16.71M | 12.22M | 14.38M | 11.33M | 11.66M | 11.91M | 13.27M | 2.62M | 1.8M |
| Net Debt | -450.47K | 29.16M | 137.15M | 304.44M | 105.98M | -186.41M | 84.9M | 208.86M | 5.41M | 122.91M | -55.11M | -21.55M | -27.16M | -28.4M | -21.66M | -1.06M | -8.87M | -18.54M | -43.74M | -26.33M | -66.82M | -40.25M | -1.49M | 404.16K |
| Debt / Equity | 0.55x | 0.55x | 0.47x | 0.73x | 0.43x | 0.37x | 0.68x | 0.97x | 0.27x | 0.57x | 0.13x | 0.12x | 0.14x | 0.11x | 0.11x | 0.11x | 0.09x | 0.13x | 0.08x | 0.07x | 0.09x | 0.09x | 0.04x | - |
| Debt / EBITDA | -9.44x | - | - | 17.93x | 4.87x | 4.60x | 5.75x | 4.67x | 1.05x | 3.26x | 0.67x | 0.97x | 10.00x | - | 3.10x | 1.41x | 1.69x | - | - | - | - | - | - | - |
| Net Debt / EBITDA | 0.01x | - | - | 6.70x | 1.02x | -1.67x | 0.81x | 1.87x | 0.05x | 2.11x | -1.27x | -0.91x | -12.60x | - | -3.86x | -0.09x | -1.23x | - | - | - | - | - | - | - |
| Interest Coverage | -7.70x | -9.75x | -15.58x | -5.87x | -10.71x | 26.61x | 4.05x | 5.09x | 28.79x | 21.27x | 22.63x | 8.24x | -2.91x | -12.42x | -2.32x | 3.83x | 5.47x | -102.51x | -89.55x | -30.69x | -49.32x | -49.91x | - | - |
| Total Equity | 700.35M | 813.36M | 952.52M | 1.12B | 1.19B | 1.38B | 886.41M | 535.47M | 424.88M | 331.75M | 213.94M | 187.09M | 158.38M | 158.97M | 152.55M | 147.25M | 132.64M | 111.49M | 149.86M | 170.55M | 137.18M | 148.67M | 61.06M | -62.37M |
| Equity Growth % | -77.92% | -14.61% | -14.95% | -5.67% | -13.83% | 55.42% | 65.54% | 26.03% | 28.07% | 55.07% | 14.35% | 18.13% | -0.37% | 4.21% | 3.6% | 11.01% | 18.97% | -25.61% | -12.13% | 24.33% | -7.73% | 143.47% | 197.9% | - |
| Book Value per Share | 1.97 | 2.29 | 2.69 | 3.16 | 3.36 | 4.14 | 2.88 | 1.79 | 1.44 | 1.14 | 0.81 | 0.68 | 0.60 | 0.66 | 0.65 | 0.63 | 0.61 | 0.52 | 0.79 | 1.19 | 2.34 | 2.76 | 1.41 | -34.72 |
| Total Shareholders' Equity | 700.35M | 813.36M | 952.52M | 1.12B | 1.19B | 1.38B | 886.41M | 535.47M | 424M | 330.75M | 213.03M | 185.5M | 158.38M | 158.97M | 152.55M | 147.25M | 132.16M | 110.87M | 149.86M | 170.55M | 137.18M | 148.67M | 61.06M | -62.37M |
| Common Stock | 178.06M | 177.7M | 177.55M | 177.19M | 176.95M | 176.61M | 200.56M | 169.39M | 149.06M | 147.53M | 133.05M | 132.58M | 131.71M | 131.46M | 118.55M | 118.32M | 115.6M | 108.84M | 108.84M | 73.87M | 68.08M | 62.76M | 17.7K | 794 |
| Retained Earnings | -898.76M | -775.56M | -672.37M | -476.29M | -392.38M | -216.42M | -529.36M | -495.22M | -481.01M | -566.73M | -592.93M | -622.31M | -638.83M | -631.85M | -606.42M | -608.89M | -615.64M | -618.9M | -573.38M | -495.09M | -506.88M | -474.41M | -89.98M | -65.14M |
| Treasury Stock | -1.14M | -1.55M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1K | 0 | 0 | 0 | -99K | -83K | 0 | 0 | 0 |
| Accumulated OCI | -38.36M | -45.09M | -7.35M | -30.64M | -37.4M | -12.64M | -45.91M | -21.96M | -27.2M | -28.9M | -25.15M | -18.51M | -23.17M | -27.41M | -25.5M | -35.07M | -26.68M | -27.48M | -26.84M | -27.48M | -65.31M | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 876K | 992K | 901K | 1.59M | 0 | 0 | 0 | 0 | 476K | 613K | 0 | 0 | -6K | 0 | 0 | 0 |
Liquidity and solvency pressure
As reported in financial statements, Evotec's total equity has declined from $1.1 billion in 2024Q3 to $700.3 million by 2026Q1, reflecting a persistent erosion of the capital base driven by ongoing net losses and the accumulation of a significant deficit in retained earnings.
The consistent decline in equity suggests that the company is consuming its internal resources to fund operations rather than generating self-sustaining growth. This trajectory warrants close monitoring, as the depletion of equity buffers reduces the company's financial flexibility during periods of operational stress.
Based on reported figures, Evotec maintains a debt-to-equity ratio of 0.55 as of 2026Q1, which appears deceptively stable while the company's ability to service this debt is increasingly compromised by the lack of consistent operating cash flow and a shrinking equity base.
While the headline leverage ratio remains within a manageable range, the reliance on debt to fund capital-intensive infrastructure like J.POD facilities creates a fixed-cost burden that is difficult to service without milestone-driven revenue. Investors should consider whether current debt levels are sustainable if the company fails to achieve a timely pivot to positive operating margins.
According to recent SEC filings, Evotec's net PPE remains a substantial component of the balance sheet at $531.4 million, indicating a heavy reliance on physical infrastructure that has yet to demonstrate the utilization rates necessary to drive meaningful return on invested capital.
The high concentration of assets in specialized laboratory and manufacturing facilities suggests an asset-heavy business model that is highly sensitive to volume fluctuations. This capital intensity creates a significant hurdle for profitability, as the depreciation of these assets continues to weigh on the bottom line regardless of current operational output.
As evidenced by the quarterly data, Evotec's cash position fluctuated significantly from $510.9 million in 2023Q4 to $388.3 million in 2026Q1, highlighting a precarious liquidity profile that remains highly sensitive to the timing of milestone payments and ongoing operational cash burn.
The current ratio of 1.68 suggests a superficial level of liquidity, but the underlying volatility in cash balances indicates that the company lacks a stable cushion against unexpected operational shocks. This liquidity profile may necessitate further external financing if the company cannot stabilize its cash conversion cycle in the near term.
Based on the provided balance sheet data, the accumulation of a negative retained earnings balance reaching $898.8 million by 2026Q1 serves as a critical indicator of long-term value destruction that may not be fully captured by headline asset or debt figures.
This deep deficit suggests that the company's historical investments have not yet translated into sustainable profitability, raising questions about the long-term viability of the current capital allocation strategy. Investors should investigate whether this trend indicates a structural impairment of the business model rather than merely temporary operational headwinds.
Quick answers to the most common questions about buying EVO stock.
As of 2025, Evotec SE (EVO) had total assets of $1.78B including $762.6M in current assets.
Evotec SE (EVO) carries total debt of $447.5M, offset by $476.2M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Evotec SE (EVO) has total shareholders' equity (book value) of $813.4M ($2.29 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Evotec SE (EVO) reported a current ratio of 2.07x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.